{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "angiotensin-converting enzyme", "coronavirus", "new drug discovery", "phytotherapy", "plant extracts"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34985368", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "10"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "05"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["2515690X211053641", "10.1177/2515690X211053641"], "Journal": {"ISSN": "2515-690X", "JournalIssue": {"Volume": "27", "PubDate": {"Year": "2022", "Season": "Jan-Dec"}}, "Title": "Journal of evidence-based integrative medicine", "ISOAbbreviation": "J Evid Based Integr Med"}, "ArticleTitle": "COVID-19: General Strategies for Herbal Therapies.", "Pagination": {"StartPage": "2515690X211053641", "MedlinePgn": "2515690X211053641"}, "Abstract": {"AbstractText": ["The coronavirus disease-2019 (COVID-19) pandemic started in early 2020 with the outbreak of a highly pathogenic human coronavirus. The world is facing a challenge and there is a pressing need for efficient drugs. Plants and natural compounds are a proven rich resource for new drug discovery. Considering the potential of natural products to manage the pandemic, this article was designed to provide an inclusive map of the stages and pathogenetic mechanisms for effective natural products on COVID-19. New drug discovery for the COVID-19 pandemic can encompass both prevention and disease management strategies. Preventive mechanisms that may be considered include boosting the immune response and hand hygiene in the preexposure phase; and blocking of virus binding and entry in the postexposure phase. Potential therapeutic target mechanisms include virus-directed therapies and host-directed therapies. Several medicinal plants and natural products, such as <i>Withania somnifera</i> (L.) Dunal and propolis for prevention; <i>Tanacetum parthenium</i> (L.) for treatment; and <i>Ammoides verticillata</i> (Desf.) Briq and <i>Nigella sativa</i> L. for both prevention and treatment have been found effective and are good targets for future research. The examples of phytochemical compounds that may be effective include aloin and terpenes as anti-septics; isothymol, dithymoquinone, and glycyrrhizin as inhibitors of virus binding and entry; glycyrrhizin, and berberine as replication suppressants; ginsenoside Rg1 and parthenolide as immunomodulators; and eriocitrin, rhoifolin, hesperidin, naringin, rutin, and veronicastroside as anti-complements. Recognizing different mechanisms of fighting against this virus can lead to a more systematic approach in finding natural products and medicinal plants for COVID-19 prevention and treatment."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "48439Department of Traditional Pharmacy, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Soleymani", "ForeName": "Samaneh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "48439Department of Traditional Medicine, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Naghizadeh", "ForeName": "Ayeh", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "48439Department of Traditional Medicine, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Karimi", "ForeName": "Mehrdad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "48439Department of Traditional Medicine, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Zarei", "ForeName": "Azadeh", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "48439Department of Traditional Pharmacy, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Mardi", "ForeName": "Raefeh", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "48439Department of Traditional Pharmacy, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Kordafshari", "ForeName": "Gholamreza", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "48439Department of Traditional Pharmacy, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Esmaealzadeh", "ForeName": "Niusha", "Initials": "N"}, {"Identifier": ["0000-0003-4351-3861"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "48439Department of Traditional Pharmacy, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Zargaran", "ForeName": "Arman", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Evid Based Integr Med", "NlmUniqueID": "101719675", "ISSNLinking": "2515-690X"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}], "CoiStatement": "<b>Declaration of Conflicting Interests:</b> The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Lipsitch M, Swerdlow DL, Finelli L. Defining the epidemiology of COVID-19\u2014studies needed. N Engl J Med. 2020;382(13):1194-1196.", "ArticleIdList": ["32074416"]}, {"Citation": "Vivek-Ananth R Rana A Rajan N, et al. In silico identification of potential natural product inhibitors of human proteases key to SARS-CoV-2 infection. Molecules 2020;25(17):3822.", "ArticleIdList": ["PMC7504347", "32842606"]}, {"Citation": "WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/\n(accessed November 20, 2020)."}, {"Citation": "Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433.", "ArticleIdList": ["PMC7127067", "32113704"]}, {"Citation": "Shi Y, Wang Y, Shao C, et al.. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27:1451-1454.", "ArticleIdList": ["PMC7091918", "32205856"]}, {"Citation": "Liu Z, Xiao X, Wei X, et al.. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. 2020;92(6):595-601.", "ArticleIdList": ["PMC7228221", "32100877"]}, {"Citation": "Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506.", "ArticleIdList": ["PMC7159299", "31986264"]}, {"Citation": "Petrovska BB. Historical review of medicinal plants\u2019 usage. Pharmacogn Rev. 2012;6(11):1.", "ArticleIdList": ["PMC3358962", "22654398"]}, {"Citation": "Pan S-Y, Zhou S-F, Gao S-H, et al.. New perspectives on how to discover drugs from herbal medicines: CAM\u2019s outstanding contribution to modern therapeutics. Evid Based Complementary Altern Med. 2013;2013:1-25.", "ArticleIdList": ["PMC3619623", "23634172"]}, {"Citation": "Zaman W, Saqib S, Ullah F, . et al.. COVID-19: phylogenetic approaches may help in finding resources for natural cure. Phytother Res. 2020;34(11):2783-2785.", "ArticleIdList": ["PMC7405213", "32648294"]}, {"Citation": "Rosales-Mendoza S. Will plant-made biopharmaceuticals play a role in the fight against COVID-19? Expert Opin Biol Ther. 2020;20(6):545-548.", "ArticleIdList": ["PMC7157952", "32250170"]}, {"Citation": "Khan S, Ali A, Shi H, . et al.. COVID-19: clinical aspects and therapeutics responses. Saudi Pharm J. 2020;28(8):1004-1008.", "ArticleIdList": ["PMC7332461", "32788835"]}, {"Citation": "Jalali A, Dabaghian F, Akbrialiabad H, Foroughinia F, Zarshenas MM. A pharmacology-based comprehensive review on medicinal plants and phytoactive constituents possibly effective in the management of COVID-19. Phytother Res. 2021;35(4):1925-1938.", "ArticleIdList": ["33159391"]}, {"Citation": "Benarba B, Pandiella A. Medicinal plants as sources of active molecules against COVID-19. Front Pharmacol. 2020;11:1-16.", "ArticleIdList": ["PMC7427466", "32848790"]}, {"Citation": "Adhikari B, Marasini BP, Rayamajhee B, et al.. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: a review. Phytother Res. 2021;35(3):1298-1312.", "ArticleIdList": ["PMC7675695", "33037698"]}, {"Citation": "Mrityunjaya M, Pavithra V, Neelam R, et al.. Immune-boosting, antioxidant and anti-inflammatory food supplements targeting pathogenesis of COVID-19. Front Immunol. 2020;11:1-12.", "ArticleIdList": ["PMC7575721", "33117359"]}, {"Citation": "Arshad MS, Khan U, Sadiq A, et al.. Coronavirus disease (COVID-19) and immunity booster green foods: a mini review. Food Sci Nutr. 2020;8(8):3971-3976.", "ArticleIdList": ["PMC7300634", "32837716"]}, {"Citation": "Zahedipour F, Hosseini SA, Sathyapalan T, et al.. Potential effects of curcumin in the treatment of COVID-19 infection. Phytother Res. 2020; 34(11):2911-2920.", "ArticleIdList": ["PMC7276879", "32430996"]}, {"Citation": "Bae G-S, Kim M-S, Jung W-S, et al.. Inhibition of lipopolysaccharide-induced inflammatory responses by piperine. Eur J Pharmacol. 2010;642(1\u20133):154-162.", "ArticleIdList": ["20621590"]}, {"Citation": "Donma MM, Donma O. The effects of Allium Sativum on immunity within the scope of COVID-19 infection. Med Hypotheses. 2020;144:109934.", "ArticleIdList": ["PMC7265825", "32512493"]}, {"Citation": "Arreola R, Quintero-Fabi\u00e1n S, L\u00f3pez-Roa RI, et al.. Immunomodulation and anti-inflammatory effects of garlic compounds. J Immunol Res. 2015;2015:401630.", "ArticleIdList": ["PMC4417560", "25961060"]}, {"Citation": "Mirabeau TY, Samson ES. Effect of Allium cepa and Allium sativum on some immunological cells in rats. Afr J Tradit Complement Altern Med. 2012;9(3):374-379.", "ArticleIdList": ["PMC3746674", "23983369"]}, {"Citation": "Daverey A, Dutta K. COVID-19: eco-friendly hand hygiene for human and environmental safety. J Environ Chem Eng. 2020: 9(2);104754.", "ArticleIdList": ["PMC7657077", "33200069"]}, {"Citation": "Li X, Duan S, Chu C, et al.. Melaleuca alternifolia concentrate inhibits in vitro entry of influenza virus into host cells. Molecules. 2013;18(8):9550-9566.", "ArticleIdList": ["PMC6270578", "23966077"]}, {"Citation": "Abdelli I, Hassani F, Bekkel Brikci S, Ghalem S. In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from western Algeria. J Biomol Struct Dyn. 2020;39(9):1-14.", "ArticleIdList": ["PMC7232889", "32362217"]}, {"Citation": "Ahmad S, Abbasi HW, Shahid S, Gul S, Abbasi SW. Molecular docking, simulation and MM-PBSA studies of nigella sativa compounds: a computational quest to identify potential natural antiviral for COVID-19 treatment. J Biomol Struct Dyn. 2020;39(12):4225-4233.", "ArticleIdList": ["PMC7298883", "32462996"]}, {"Citation": "Boozari M, Hosseinzadeh H. Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies. Phytother Res. 2020;35(2):864-876.", "ArticleIdList": ["32985017"]}, {"Citation": "G\u00fcler HI, Tatar G, Yildiz O, Belduz AO, Kolayli S. Investigation of potential inhibitor properties of ethanolic propolis extracts against ACE-II receptors for COVID-19 treatment by molecular docking study. ScienceOpen Preprints. 2020; 203(6):3557-3564.", "ArticleIdList": ["PMC8098016", "33950349"]}, {"Citation": "Yang L, Li Y-T, Miao J, et al.. Network pharmacology studies on the effect of Chai-Ling decoction in coronavirus disease 2019. J Tradit Complement Med. 2020;5(3):145-159."}, {"Citation": "Sekiou O Bouziane I Bouslama Z, et al. In-Silico Identification of Potent Inhibitors of COVID-19 Main Protease (Mpro) from Natural Products. Int J Biochem Physiol. 2020; 5(3): 1-12."}, {"Citation": "Kumar V, Dhanjal JK, Bhargava P, et al.. Withanone and withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells. J Biomol Struct Dyn. 2020:1-13.", "ArticleIdList": ["PMC7309304", "32469279"]}, {"Citation": "Chowdhury P. In silico investigation of phytoconstituents from Indian medicinal herb \u2018Tinospora cordifolia (giloy)\u2019 against SARS-CoV-2 (COVID-19) by molecular dynamics approach. J Biomol Struct Dyn. 2020;39(17):6792-6809.", "ArticleIdList": ["PMC7484574", "32762511"]}, {"Citation": "Ulasli M, Gurses SA, Bayraktar R, et al.. The effects of Nigella sativa (Ns), Anthemis hyalina (Ah) and Citrus sinensis (Cs) extracts on the replication of coronavirus and the expression of TRP genes family. Mol Biol Rep. 2014;41(3):1703-1711.", "ArticleIdList": ["PMC3933739", "24413991"]}, {"Citation": "Chikhale RV, Sinha SK, Patil RB, et al.. In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19. J Biomol Struct Dyn. 2020;39(14):5033-5047.", "ArticleIdList": ["32579064"]}, {"Citation": "Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. The Lancet. 2003;361(9374):2045-2046.", "ArticleIdList": ["PMC7112442", "12814717"]}, {"Citation": "Chen LF, Zhong YL, Luo D, et al.. Antiviral activity of ethanol extract of Lophatherum gracile against respiratory syncytial virus infection. J Ethnopharmacol. 2019;242:111575.", "ArticleIdList": ["30391397"]}, {"Citation": "Lee EJ, Ko E, Lee J, et al.. Ginsenoside Rg1 enhances CD4(\u2009+\u2009) T-cell activities and modulates Th1/Th2 differentiation. Int Immunopharmacol. 2004;4(2):235-244.", "ArticleIdList": ["14996415"]}, {"Citation": "Bahrami M, Kamalinejad M, Latifi SA, Seif F, Dadmehr M. Cytokine storm in COVID-19 and parthenolide: preclinical evidence. Phytother Res. 2020;34(10):2429-2430.", "ArticleIdList": ["PMC7300884", "32472655"]}, {"Citation": "Nikolai G, Friedl P, Werner M, Niggemann B, Z\u00e4nker KS. Effect of a mistletoe extract (Iscador QuFrF) on viability and migratory behavior of human peripheral CD4+and CD8+\u2009T lymphocytes in three-dimensional collagen lattices. In Vitro Cell Dev Biol Animal. 1997;33(9):710-716.", "ArticleIdList": ["9358287"]}, {"Citation": "Kim EH, Shim B, Kang S, et al.. Anti-inflammatory effects of Scutellaria baicalensis extract via suppression of immune modulators and MAP kinase signaling molecules. J Ethnopharmacol. 2009;126(2):320-331.", "ArticleIdList": ["19699788"]}, {"Citation": "Berretta AA, Silveira MAD, C\u00f3ndor Capcha JM, De Jong D. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: running title: propolis against SARS-CoV-2 infection and COVID-19. Biomed Pharmacother. 2020;131:110622.", "ArticleIdList": ["PMC7430291", "32890967"]}, {"Citation": "Austarheim I, Pham AT, Nguyen C, et al.. Antiplasmodial, anti-complement and anti-inflammatory in vitro effects of Biophytum umbraculum welw. Traditionally used against cerebral malaria in Mali. J Ethnopharmacol. 2016;190:159-164.", "ArticleIdList": ["27260410"]}, {"Citation": "Shen C-Y, Jiang J-G, Huang C-L, Zhu W, Zheng C-Y. Polyphenols from blossoms of Citrus aurantium L. var. amara engl. Show significant anti-complement and anti-inflammatory effects. J Agric Food Chem. 2017;65(41):9061-9068.", "ArticleIdList": ["28942652"]}, {"Citation": "Patil A, Kakde M. Medicinal plant as a natural immunity booster for COVID-19\u2014a review. Ind J Integr Med. 2020; 2(2):24-27."}, {"Citation": "Berardi A, Perinelli DR, Merchant HA, et al.. Hand sanitisers amid COVID-19: a critical review of alcohol-based products on the market and formulation approaches to respond to increasing demand. Int J Pharm. 2020; 584:119431.", "ArticleIdList": ["PMC7229736", "32461194"]}, {"Citation": "Mpiana PT, Tshibangu DS, Kilembe JT, et al.. Aloe vera (L.) Burm. F. as a potential anti-COVID-19 plant: a mini-review of Its antiviral activity. Eur J Med Plants. 2020;31(8):86-93."}, {"Citation": "Boopathi S, Poma AB, Kolandaivel P. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. J Biomol Struct Dyn. 2020;39(9): 3409-3418", "ArticleIdList": ["PMC7196923", "32306836"]}, {"Citation": "Babadaei MMN, Hasan A, Bloukh SH, et al.. The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets. J Biomol Struct Dyn. 2020;39(10):3780-3786.", "ArticleIdList": ["PMC7284141", "32397951"]}, {"Citation": "Bekhechi C, Boti JB, Bekkara FA, Abdelouahid DE, Casanova J, Tomi F. Isothymol in Ajowan essential oil. Nat Prod Commun. 2010;5(7):1107-1110.", "ArticleIdList": ["20734951"]}, {"Citation": "Koshak DAE, Koshak PEA. Nigella sativa L as a potential phytotherapy for coronavirus disease 2019: a mini review of in silico studies. Curr Ther Res Clin Exp. 2020;93:100602.", "ArticleIdList": ["PMC7445151", "32863400"]}, {"Citation": "Boozari M, Hosseinzadeh H. Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies. Phytother Res. 2020; 35(2):864-876.", "ArticleIdList": ["32985017"]}, {"Citation": "Wach A, Biesaga M. Quercetin content in some food and herbal samples. Food Chem. 2007;100(2):699-704."}, {"Citation": "Williamson G, Kerimi A. Testing of natural products in clinical trials targeting the SARS-CoV-2 (COVID-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction. Biochem Pharmacol. 2020;178:114123.", "ArticleIdList": ["PMC7316054", "32593613"]}, {"Citation": "Antonio AdS, Wiedemann LSM, Veiga-Junior VF. Natural products\u2019 role against COVID-19. RSC Adv. 2020;10(39):23379-23393.", "ArticleIdList": ["PMC9122563", "35693131"]}, {"Citation": "Zhou N, Pan T, Zhang J, et al.. Glycopeptide antibiotics potently inhibit cathepsin L in the late endosome/lysosome and block the entry of Ebola virus, Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV). J Biol Chem. 2016;291(17):9218-9232.", "ArticleIdList": ["PMC4861487", "26953343"]}, {"Citation": "Vivek-Ananth RP Rana A Rajan N, et al. In silico identification of potential natural product inhibitors of human proteases key to SARS-CoV-2 infection. Molecules. 2020;25(17):3822.", "ArticleIdList": ["PMC7504347", "32842606"]}, {"Citation": "Leung P-C. The efficacy of Chinese medicine for SARS: a review of Chinese publications after the crisis. Am J Chin Med. 2007;35(4):575-581.", "ArticleIdList": ["17708624"]}, {"Citation": "Li S-Y, Chen C, Zhang H-Q, et al.. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 2005;67(1):18-23.", "ArticleIdList": ["PMC7114104", "15885816"]}, {"Citation": "Lin L-T, Hsu W-C, Lin C-C. Antiviral natural products and herbal medicines. J Tradit Complement Med. 2014;4(1):24-35.", "ArticleIdList": ["PMC4032839", "24872930"]}, {"Citation": "Chojnacka K, Witek-Krowiak A, Skrzypczak D, Mikula K, M\u0142ynarz P. Phytochemicals containing biologically active polyphenols as an effective agent against COVID-19-inducing coronavirus. J Funct Foods. 2020;73:104146.", "ArticleIdList": ["PMC7392194", "32834835"]}, {"Citation": "Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1-23.", "ArticleIdList": ["PMC4369385", "25720466"]}, {"Citation": "Tanaka Y, Sato Y, Sasaki T. Suppression of coronavirus replication by cyclophilin inhibitors. Viruses. 2013;5(5):1250-1260.", "ArticleIdList": ["PMC3712306", "23698397"]}, {"Citation": "Chen C-J, Michaelis M, Hsu H-K, et al.. Toona sinensis roem tender leaf extract inhibits SARS coronavirus replication. J Ethnopharmacol. 2008;120(1):108-111.", "ArticleIdList": ["PMC7127248", "18762235"]}, {"Citation": "Kim H-Y, Shin H-S, Park H, et al.. In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex. J Clin Virol. 2008;41(2):122-128.", "ArticleIdList": ["PMC7108295", "18036887"]}, {"Citation": "Kim H-Y, Eo E-Y, Park H, et al.. Medicinal herbal extracts of Sophorae radix, acanthopanacis cortex, Sanguisorbae radix and Torilis fructus inhibit coronavirus replication in vitro. Antivir Ther. 2010;15(5):697-709.", "ArticleIdList": ["20710051"]}, {"Citation": "Fiore C, Eisenhut M, Krausse R, et al.. Antiviral effects of Glycyrrhiza species. Phytother Res. 2008;22(2):141-148.", "ArticleIdList": ["PMC7167979", "17886224"]}, {"Citation": "Bailly C, Vergoten G. Glycyrrhizin: an alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome? Pharmacol Therapeut. 2020;214:107618.", "ArticleIdList": ["PMC7311916", "32592716"]}, {"Citation": "Goyal P, Choi JJ, Pinheiro LC, et al.. Clinical characteristics of COVID-19 in New York City. N Engl J Med. 2020;382(24):2372-2374.", "ArticleIdList": ["PMC7182018", "32302078"]}, {"Citation": "Stratton CW, Tang YW, Lu H. Pathogenesis-directed therapy of 2019 novel coronavirus disease. J Med Virol. 2020;93(3):1320-1342.", "ArticleIdList": ["33073355"]}, {"Citation": "Villapol S. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. Transl Res. 2020;226:57-69.", "ArticleIdList": ["PMC7438210", "32827705"]}, {"Citation": "Paliwal VK, Garg RK, Gupta A, Tejan N. Neuromuscular presentations in patients with COVID-19. J Neurol Sci. 2020;41(11):3039-3056.", "ArticleIdList": ["PMC7491599", "32935156"]}, {"Citation": "Bridwell R, Long B, Gottlieb M. Neurologic complications of COVID-19. Am J Emerg Med. 2020;38(7):1549.e3\u2013.e7.", "ArticleIdList": ["PMC7229718", "32425321"]}, {"Citation": "Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14(3):247-250.", "ArticleIdList": ["PMC7102662", "32247212"]}, {"Citation": "Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-637.", "ArticleIdList": ["PMC7167720", "15141377"]}, {"Citation": "Martines RB, Ritter JM, Matkovic E, et al.. Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States. Emerg Infect Dis. 2020;26(9):2005-2015.", "ArticleIdList": ["PMC7454055", "32437316"]}, {"Citation": "Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respiratory Soc. 2020;55(4):2000607.", "ArticleIdList": ["PMC7144260", "32269085"]}, {"Citation": "Garc\u00eda LF. Immune response, inflammation, and the clinical spectrum of COVID-19. Front Immunol. 2020;11(1441):1-13.", "ArticleIdList": ["PMC7308593", "32612615"]}, {"Citation": "Swain SL, McKinstry KK, Strutt TM. Expanding roles for CD4+T cells in immunity to viruses. Nat Rev Immunol. 2012;12(2):136-148.", "ArticleIdList": ["PMC3764486", "22266691"]}, {"Citation": "Diao B, Wang C, Tan Y, et al.. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol. 2020;11(827):1-14.", "ArticleIdList": ["PMC7205903", "32425950"]}, {"Citation": "Li G, Fan Y, Lai Y, et al.. Coronavirus infections and immune responses. J Med Virol. 2020 ;92(4):424.-.", "ArticleIdList": ["PMC7166547", "31981224"]}, {"Citation": "Donma MM, Donma O. The effects of allium sativum on immunity within the scope of COVID-19 infection. Med Hypotheses. 2020;144:109934.", "ArticleIdList": ["PMC7265825", "32512493"]}, {"Citation": "Wang Y, Jung YJ, Kim KH, et al.. Antiviral activity of fermented Ginseng extracts against a broad range of influenza viruses. Viruses. 2018;10(9): 471.", "ArticleIdList": ["PMC6164659", "30200514"]}, {"Citation": "Nagai T, Suzuki Y, Tomimori T, Yamada H. Antiviral activity of plant flavonoid, 5,7,4\u2032-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis against influenza A (H3N2) and B viruses. Biol Pharm Bull. 1995;18(2):295-299.", "ArticleIdList": ["7742801"]}, {"Citation": "Liu Q, Zhou Y-h, Yang Z-q. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol Immunol. 2016;13(1):3-10.", "ArticleIdList": ["PMC4711683", "26189369"]}, {"Citation": "Spanopoulou C, Kassimos D, Cassimos D. Potential role of anti-complement agents in the treatment of COVID-19-related ARDS. Mediterr J Rheumatol. 2020;31(Suppl 2):304-305.", "ArticleIdList": ["PMC7656134", "33196010"]}, {"Citation": "Lu Y, Jiang Y, Ling L, Zhang Y, Li H, Chen D. Beneficial effects of Houttuynia cordata polysaccharides on \u201ctwo-hit\u201d acute lung injury and endotoxic fever in rats associated with anti-complementary activities. Acta Pharm Sin B. 2018;8(2):218-227.", "ArticleIdList": ["PMC5925397", "29719782"]}, {"Citation": "Gottlieb M, Long B. Dermatologic manifestations and complications of COVID-19. Am J Emerg Med. 2020;38(9):1715-1721.", "ArticleIdList": ["PMC7274995", "32731141"]}, {"Citation": "Magro C, Mulvey JJ, Berlin D, et al.. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020;220:1-13.", "ArticleIdList": ["PMC7158248", "32299776"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "5", "Hour": "12", "Minute": "16"}, {"Year": "2022", "Month": "1", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "5"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34985368", "PMC8744081", "10.1177/2515690X211053641"]}}], "PubmedBookArticle": []}